Fidelity Investments
VERA icon

Fidelity Investments’s Vera Therapeutics VERA Stock Holding History

Fidelity Investments’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$108M Sell
2,676,422
-209,431
-7% -$9.02M 0.01% 1139
2025
Q4 		$146M Buy
2,885,853
+42,722
+2% +$1.52M 0.01% 1011
2025
Q3 		$82.6M Sell
2,843,131
-66,833
-2% -$1.55M ﹤0.01% 1258
2025
Q2 		$68.6M Sell
2,909,964
-322,355
-10% -$7.25M ﹤0.01% 1268
2025
Q1 		$77.6M Buy
3,232,319
+179,193
+6% +$5.76M 0.01% 1190
2024
Q4 		$129M Buy
3,053,126
+267,842
+10% +$11.9M 0.01% 1009
2024
Q3 		$123M Sell
2,785,284
-16,654
-0.6% -$632K 0.01% 1013
2024
Q2 		$101M Sell
2,801,938
-321,330
-10% -$12.7M 0.01% 1035
2024
Q1 		$135M Buy
3,123,268
+348,896
+13% +$12.4M 0.01% 940
2023
Q4 		$42.7M Sell
2,774,372
-2,670,994
-49% -$33.9M ﹤0.01% 1350
2023
Q3 		$74.7M Sell
5,445,366
-1,090,194
-17% -$18.7M 0.01% 1094
2023
Q2 		$105M Buy
6,535,560
+739,301
+13% +$6.68M 0.01% 973
2023
Q1 		$45M Buy
5,796,259
+1,647,613
+40% +$12.7M ﹤0.01% 1302
2022
Q4 		$80.3M Buy
4,148,646
+92,305
+2% +$1.67M 0.01% 1056
2022
Q3 		$86.4M Buy
4,056,341
+40,990
+1% +$767K 0.01% 1010
2022
Q2 		$54.6M Buy
4,015,351
+3,321
+0.1% +$58K 0.01% 1221
2022
Q1 		$94.2M Buy
4,012,030
+866,828
+28% +$18.7M 0.01% 1089
2021
Q4 		$84M Buy
3,145,202
+5,800
+0.2% +$128K 0.01% 1190
2021
Q3 		$52.6M Buy
3,139,402
+16,890
+0.5% +$302K ﹤0.01% 1386
2021
Q2 		$38.5M Buy
+3,122,512
New +$48.5M ﹤0.01% 1556

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Fidelity Investments's VERA Position: Q1 2026 in Review

Fidelity Investments reduced its Vera Therapeutics (VERA) stake by 7.3% in Q1 2026, selling an estimated $9.02M and leaving 2,676,422 shares worth $108M. The position accounts for 0.01% of the portfolio, ranked #1139.

Fidelity Investments first reported a position in VERA in Q2 2021 and has held it in 20 quarters since. The position peaked at $146M in Q4 2025. 229 funds tracked by Wall St. Rank hold VERA as of Q1 2026.

  • Fidelity Investments held 2,676,422 shares of Vera Therapeutics worth $108M as of Q1 2026.
  • Fidelity Investments sold 209,431 Vera Therapeutics shares in Q1 2026, an estimated $9.02M.
  • Vera Therapeutics made up 0.01% of Fidelity Investments's portfolio in Q1 2026, its #1139 holding.
  • Fidelity Investments first reported a position in Vera Therapeutics in Q2 2021 and has held it in 20 quarters since.
  • Fidelity Investments's Vera Therapeutics position peaked at $146M in Q4 2025.
  • 229 funds tracked by Wall St. Rank held Vera Therapeutics as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.